141 related articles for article (PubMed ID: 27624738)
1. Antithrombin Administration During Intravenous Heparin Anticoagulation in the Intensive Care Unit: A Single-Center Matched Retrospective Cohort Study.
Beyer JT; Schoeppler KE; Zanotti G; Weiss GM; Mueller SW; MacLaren R; Fish DN; Kiser TH
Clin Appl Thromb Hemost; 2018 Jan; 24(1):145-150. PubMed ID: 27624738
[TBL] [Abstract][Full Text] [Related]
2. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
[TBL] [Abstract][Full Text] [Related]
3. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
[TBL] [Abstract][Full Text] [Related]
4. Weight based heparin dosing for thromboembolic disease is associated with earlier anticoagulation in surgical patients.
Levine AR; Laliberte B; Lin H; Stan K; Ladha KS; Kaafarani HM; Lee J
Int J Surg; 2014 Dec; 12(12):1416-9. PubMed ID: 25448664
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose versus Therapeutic Range Intravenous Unfractionated Heparin Prophylaxis in the Treatment of Patients with Severe Aneurysmal Subarachnoid Hemorrhage After Aneurysm Occlusion.
Kunz M; Siller S; Nell C; Schniepp R; Dorn F; Huge V; Tonn JC; Pfister HW; Schichor C
World Neurosurg; 2018 Sep; 117():e705-e711. PubMed ID: 29959066
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation.
Morrisette MJ; Zomp-Wiebe A; Bidwell KL; Dunn SP; Gelvin MG; Money DT; Palkimas S
Perfusion; 2020 Jan; 35(1):66-72. PubMed ID: 31213179
[TBL] [Abstract][Full Text] [Related]
7. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
[TBL] [Abstract][Full Text] [Related]
8. Practice Patterns of Venous Thromboembolism Prophylaxis in Underweight, Critically Ill Patients with Neurologic Injury.
Betthauser K; Pope H; Gowan M; Human T
Neurocrit Care; 2017 Aug; 27(1):96-102. PubMed ID: 28097621
[TBL] [Abstract][Full Text] [Related]
9. Unfractionated heparin dosing for therapeutic anticoagulation in critically ill obese adults.
Hohner EM; Kruer RM; Gilmore VT; Streiff M; Gibbs H
J Crit Care; 2015 Apr; 30(2):395-9. PubMed ID: 25534987
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin concentrate in pediatric patients requiring unfractionated heparin anticoagulation: a retrospective cohort study.
Ryerson LM; Bauman ME; Kuhle S; Bruce AA; Massicotte MP
Pediatr Crit Care Med; 2014 Oct; 15(8):e340-6. PubMed ID: 24901804
[TBL] [Abstract][Full Text] [Related]
11. Association of Heparin Dose, Route, Timing, and Duration With Heparin-Induced Thrombocytopenia.
Crow JR; Nam L; Chasler JE; Ong CS; Dane KE; Kickler T; Lawton J; Streiff MB; Alejo D; Canner JK; Schena S
Ann Thorac Surg; 2021 Jul; 112(1):32-37. PubMed ID: 33217393
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of unfractionated heparin in critically ill patients.
Aarab R; van Es J; de Pont AC; Vroom MB; Middeldorp S
Neth J Med; 2013 Nov; 71(9):466-71. PubMed ID: 24218420
[TBL] [Abstract][Full Text] [Related]
13. Heparin dosing in critically ill patients undergoing therapeutic hypothermia following cardiac arrest.
Wahby KA; Jhajhria S; Dalal BD; Soubani AO
Resuscitation; 2014 Apr; 85(4):533-7. PubMed ID: 24361456
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.
Fowler RA; Mittmann N; Geerts WH; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
Trials; 2014 Dec; 15():502. PubMed ID: 25528663
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic and Anticoagulation Therapy in Patients Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis for Pulmonary Embolism.
Terry KJ; Buckley LF; Aldemerdash A; Fanikos J; Dell'Orfano H
Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):132-135. PubMed ID: 28891451
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nafamostat mesilate and unfractionated heparin as anticoagulants during continuous renal replacement therapy.
Makino S; Egi M; Kita H; Miyatake Y; Kubota K; Mizobuchi S
Int J Artif Organs; 2016 Jan; 39(1):16-21. PubMed ID: 26868216
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: the FAST-MI registry.
Puymirat É; Aissaoui N; Silvain J; Bonello L; Cuisset T; Motreff P; Bataille V; Durand E; Cottin Y; Simon T; Danchin N;
Arch Cardiovasc Dis; 2012; 105(6-7):347-54. PubMed ID: 22800719
[TBL] [Abstract][Full Text] [Related]
19. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397
[TBL] [Abstract][Full Text] [Related]
20. Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency.
Park D; Southern W; Calvo M; Kushnir M; Solorzano C; Sinnet M; Billett HH
J Gen Intern Med; 2016 Feb; 31(2):182-187. PubMed ID: 26209179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
